ANTICANCER ACTIVITY OF TERMINALLIA ARJUNA AGAINST HUMAN CANCER LINE CELL
In -vitro cytotoxicity testing has become an integral aspect of drug discovery because it is a convenient, cost effective, and predictive means of characterizing the toxic potential of new chemical entities. The early and routine implementation of this testing is testament to its prognostic importance for humans. Anticancer activity of different concentrations (20-100) of plant extract Terminallia arjuna was shown against Hep3-B. MTT [(3, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazoliumbromidee)] assay was done in-vitro cytotoxity test. The low concentration does not show the activities were as extract with 80μl and 100μl concentration showed the activity against Human hepatoma cell line.